Search clinical trials for: Repaglinide, Bupropion and SHR3680

Total 487 results

Thomas Jefferson University

Active, not recruiting

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Head and Neck Squamous Cell Carcinoma | Lung Non-Small Cell Carcinoma

United States
The University of Texas Medical Branch, Galveston
National Institute on Drug Abuse (NIDA); UConn Health

Completed

Bupropion for Smoking Cessation During Pregnancy

Tobacco Use Disorder | Pregnancy Related

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); GlaxoSmithKline

Completed

Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)

Depression | HIV Infections

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions

Healthy
Massachusetts General Hospital

Terminated

Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

Schizophrenia | Nicotine Dependence

United States
Watching Over Mothers & Babies Foundation
University of Arizona

Completed

Bupropion for Smoking Cessation in Pregnancy

Smoking Cessation | Pregnancy

United States
Yu-Li Hospital
National Health Research Institutes, Taiwan; Department of Health, Executive...

Completed

The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia (PSIAARP)

Schizophrenia | Tobacco Dependence

Taiwan
Vanderbilt University
Janssen Pharmaceutica

Completed

Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression

Unipolar Depression

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Binge-Eating Disorder

United States
University of Leicester
University Hospital Birmingham

Completed

Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan (Can Do)

Diabetes Mellitus, Type 2

United Kingdom
ART Fertility Clinics LLC

Not yet recruiting

Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates. (GX)

Infertility | In Vitro Fertilization
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence

Substance Abuse | Cocaine Dependence

United States
Brentwood Biomedical Research Institute

Completed

Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment

Smoking Cessation | Schizophrenia

United States
Duke University

Completed

Effect of Bupropion on Seizure Threshold in Depressed Patients

MDD

United States
Vanderbilt University Medical Center

Completed

Dynamic Measures of Neurochemistry in Mood Disorders

Depression

United States
Medical University Innsbruck

Completed

Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation

Substance Abuse | Nicotine Dependence | Tobacco Dependence | Substance Dependence

Austria
Mayo Clinic

Completed

Chantix & Bupropion for Smoking Cessation (ChanBan)

Smoking | Tobacco Use Disorder

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA); Behavioral Health Services, Inc.

Completed

Pilot Trial of Bupropion Versus Placebo for Methamphetamine Abuse in Adolescents

Adolescent Methamphetamine Abuse

United States
Emory University
National Institute of Mental Health (NIMH)

Completed

Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits

Major Depression

United States
University of Malaya

Completed

Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men

Sexual Dysfunctions, Psychological | Hypoactive Sexual Desire Disorder | Erectile Dysfunctions

Malaysia
New York State Psychiatric Institute

Withdrawn

Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders

Depressive Illness

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior

Smoking Lapse Behavior

United States
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd

Completed

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Healthy Volunteers | Pharmacokinetics of Isavuconazole | Pharmacokinetics of Bupropion

United States
Mayo Clinic
National Cancer Institute (NCI); University of Minnesota

Completed

Varenicline and Bupropion for Smoking Cessation (CHANBAN)

Smoking

United States
University Health Network, Toronto
GlaxoSmithKline; H. Lundbeck A/S

Completed

Memory Functioning and Antidepressant Treatment

Depression | Major Depressive Disorder

Canada
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide

Parkinson Disease

Portugal
Henan Cancer Hospital

Active, not recruiting

Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer

Metastatic Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout

Gout

China
St. Joseph's Healthcare Hamilton
Bausch Health, Canada Inc.

Active, not recruiting

Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program. (COR-WM)

Obesity

Canada
S1 Biopharma, Inc.

Completed

Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety (PURPLE)

Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined) | Sexual Interest/Arousal Disorder (DSM-5 Defined)

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers

Rheumatoid Arthritis

China
University of Tartu

Completed

Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment

Major Depression

Estonia
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Completed

Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts

Smoking | Smoking Cessation | Tobacco Use Disorder

Canada
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions

Depression
Brown University
National Institute on Drug Abuse (NIDA)

Completed

Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic Features

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

Healthy

United States
University of California, Los Angeles

Withdrawn

Relapse Prevention in Stimulant Use Disorder

ADHD | Cognitive Function | Relapse | Stimulant Use

United States
St. Joseph's Healthcare Hamilton
Bausch Health, Canada Inc.

Active, not recruiting

A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery (COR-WR)

Obesity

Canada
VA Office of Research and Development

Completed

VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)

Major Depressive Disorder

United States
Orexigen Therapeutics, Inc

Completed

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

Healthy

United States
Orexigen Therapeutics, Inc

Completed

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Obesity | Overweight

United States
GlaxoSmithKline

Completed

Sexual Functioning Study With Antidepressants

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States
New York State Psychiatric Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Terminated

Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism

Depression | Alcoholism | Suicidal Behavior

United States
University of Minnesota
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Varenicline and Smoking Cessation in Schizophrenia (VSCS)

Smoking Cessation | Schizophrenia

United States
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)

Depression

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

Healthy

United States
American Regent, Inc.

Not yet recruiting

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Pediatric Patients >3 to 17 Years of Age Requiring Long-term Parenteral Nutrition

Manganese Safety in Pediatric Patients
Vanderbilt University Medical Center

Completed

Connectivity Affecting the Antidepressant REsponse Study (CAARE)

Major Depressive Disorder

United States

Search clinical trials for: Repaglinide, Bupropion and SHR3680

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations